摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Benzyloxy-6-chloro-3-propyl-2(1H)-quinolinone | 345912-93-8

中文名称
——
中文别名
——
英文名称
4-Benzyloxy-6-chloro-3-propyl-2(1H)-quinolinone
英文别名
4-benzyloxy-6-chloro-3-propyl-1H-quinolin-2-one;6-chloro-4-phenylmethoxy-3-propyl-1H-quinolin-2-one
4-Benzyloxy-6-chloro-3-propyl-2(1H)-quinolinone化学式
CAS
345912-93-8
化学式
C19H18ClNO2
mdl
——
分子量
327.81
InChiKey
WPCTYGSZCRKHNT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Quinolone compounds for use in treating viral infections
    申请人:——
    公开号:US20030069271A1
    公开(公告)日:2003-04-10
    The present invention relates to quinolone compounds and their use in the treatment of viral infections.
    本发明涉及喹诺酮化合物及其在治疗病毒感染中的应用。
  • QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS
    申请人:GLAXO GROUP LIMITED
    公开号:EP1244629A2
    公开(公告)日:2002-10-02
  • [EN] QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS<br/>[FR] COMPOSES DE QUINOLONE UTILISES DANS LE TRAITEMENT D'INFECTIONS VIRALES
    申请人:GLAXO GROUP LTD
    公开号:WO2001046150A2
    公开(公告)日:2001-06-28
    The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R1 is hydrogen; R2 is oxygen or sulfur; R3 is trifluoromethyl; cyano; C¿1-8?alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR?15¿, wherein R15 is C¿1-8?alkyl optionally substituted with C1-8alkyl; R?4 is OR11¿, wherein R11 is C¿2-8?alkenyl optionally substituted with C1-8alkyl; C1-8alkyl optionally substituted with C1-8alkyl; C6-14arylalkyl; C3-6cycloalkyl; C3-6cycloalkylalkyl; heterocyclealkyl; heterocyclealkynyl; C3-6cycloalkylalkenyl; C6-14arylalkynyl; C3-6cycloalkylalkynyl; SR?12¿, wherein R12 is C¿3-6?cycloalkyl; S(O)R?12¿, wherein R12 is C¿3-6?cycloalkyl; or NR?13R14¿ wherein R?13 and R14¿, which may be the same or different, are hydrogen or C¿1-8?alkyl, optionally substituted with C1-8alkyl; R?5¿ is hydrogen; nitro; halogen; C¿1-8?alkyl, optionally substituted with C1-8alkyl or trifluoromethyl; R?6¿ is hydrogen; halogen; C¿1-8?alkyl; cyano: trifluoromethyl; or OR?10¿ wherein R10 is C¿1-8?alkyl or trifluoromethyl; R?7¿ is hydrogen; C¿1-8?alkyl; halogen; C6-14aryl; C1-8alkylaryl; C2-8alkynyl; heteroaryl; or OR?9¿ wherein R9 is C¿1-8?alkyl; R?8¿ is hydrogen; halogen; cyano; nitro; or OR16, wherein R16 is hydrogen or C¿1-8?alkyl optionally substituted with C1-8alkyl or trifluoromethyl; and their use in the treatment of viral infections.
查看更多